chrisvoncsefalvay/vaers-outcomes huggingface dataset:
STROKE; This spontaneous report received from a consumer via a company representative via social media  concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, start therapy date were not reported, administered for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced stroke (dose number in series 1). The reporter stated that, "my brother also". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211248907 and 20211258956.; Sender's Comments: V0: 20211258812-COVID-19 VACCINE AD26.COV2.S-Stroke. This event is considered unassessable. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
patient reports feeling nauseous about 5 minutes after his vaccine. He then reports feeling sweaty and as if he was going to pass out. Patient appeared pale and diaphoretic. Taken back to exam room, layed flat and given cool wash rag on forehead. Symptoms subsided after approx. 3 minutes. He was slowly raised up to siting position and given water. Patient reports feeling "back to normal". Had him stay in waiting room an additional 15 minutes, normal color and skin tone/temp, left ambulatory with family.
Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion); Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  The reporter stated that their facility had not been able to download the digital data logger, they had been put on hold at the moment. There had been no power outages that would have impacted the Moderna vaccine.  It was reported that, the facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter did not have any questions and wanted to report this to Moderna.  The reporter stated that no adverse reactions were reported by any patients.
Migranes; Experiencing side effects; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migranes) and VACCINATION COMPLICATION (Experiencing side effects) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine (Susceptible to migraines).   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced MIGRAINE (Migranes) and VACCINATION COMPLICATION (Experiencing side effects). At the time of the report, MIGRAINE (Migranes) and VACCINATION COMPLICATION (Experiencing side effects) had not resolved.            Relevant concomitant medications included preventative migraine medication. Treatment information included migraine medication prescribed by doctor. Action taken with mRNA-1273 in response to the events was not applicable. After her second dose she started experiencing side effects that occurred 2 or 3 times a week and was still ongoing.
Cerebrovascular accident (CVA) due to stenosis of right middle cerebral artery (HCC) (163.511); Cerebrovascular accident (CVA) due to stenosis of right middle cerebral artery (HCC) (163.511); This is the spontaneous report from a contactable consumer (patient). This 79-year-old, nonpregnant, female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 2 at a hospital facility, via an unspecified route of administration, administered in left arm on 10Feb2021 on 09:00 am (age at vaccination 79 years; batch/lot number: FL9267) as single dose for COVID-19 immunization. Medical history included borderline high blood pressure from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported however patient reported they had medication within 2 weeks of vaccination. The patient previously took penicillin on unspecified date, and received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 1, via an unspecified route of administration, administered in right arm on 18Jan2021 at 09:15 AM (age at vaccination 79 years; batch/lot number: EL9261) as single dose for COVID-19 immunization. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination patient had been tested for COVID-19. Patient had a negative nasal swab on 22Feb2021. Patient experienced cerebrovascular accident (CVA) due to stenosis of right middle cerebral artery (HCC; 163.511) on 02Mar2021 at 01:30 which resulted in emergency room/department or urgent care. It was also reported patient had a hospitalization for 2 days. Treatment received was reported as CT and MRI of head & neck, X-ray of chest, "echocar". Patient was recovering from CVA due to stenosis of right middle cerebral artery.
I was hurting everywhere, felt like having been run over by a semi. Chest felt like it was vibrating and moving up the body. Currently has ringing in the ears.
Eye swelling, Pain NOS, cell mediated allergic reaction, Report A0368358A describes puffy eyes in an adult (over 40 y.o.) female who received Hep B vaccine recombinant (Engerix-B). The medical history included allergy to acetaminophen hydrocodone bitartrate (Vicodin). No concurrent conditions were provided. There were no concurrent medications. The vaccines had no adverse experiences following receipt of her first injection of Engerix-B. On 5/8/02, the vaccinee received her second injection of Engerix-B. Later that day, she experienced puffy eyes, without itching and "an achy feeling, like the flu". The vaccinee reported these symptoms via telephone. The reporter was "concerned that this may be a delayed hypersensitivity reaction from the first shot." The events persisted the next day. The reporting nurse considered the events to be probably not related to Engerix-B administration.
There were 4-5 individuals at the clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reaction symptoms
Three days after injection, unable to raise arm for a couple days. A week after injection, came down with shingles on left-side of face, affecting left eye.
Came in and got shot, very painful. Paid and went outside to car. Had severe pain radiate down arms and up into neck and to head then to chest bone. Ambulance called, but did not transport. BP was high. Went home pain went into back "bone". Has felt tired, unable to do anything since. Finally yesterday BP returned to normal 130/74. She went to Dr yesterday but he doesn't know what it was either.
the inj site on lt thigh found to be indurated/redness & warm;no local lymph node palpable, no joint/muscle involvement, no systemic signs or sx;no limping
Dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the date vial placed in refrigerator was on 11-Nov-2021. No concomitant medications were reported. It was reported that patient had no temperature excursion and no adverse event.  No treatment medications were reported.   This case was linked to MOD-2022-491837 (Patient Link).
Patient was dizzy and warm 15 minutes after receiving vaccines. EMS was called was examined and was told to go home with observation from family.
Increase in White blood count and kidney failure, resulting in death. Increase of white blood cell count went from completely normal to over 100,000 over a couple month time frame. At time of death, he had physically observable lymph nodes swelling all over his body and were nearly bursting from his skin on his belly. He died a horrible in hospice at home.
Headache, nausea, joint pain-especially legs, chills and severe fatigue. Lated over 3 1/2 days.
A report was received from a healthcare professional on 10/14/2003 concerning an unspecified number of vaccinees of unknown demography who received double the recommended dose of Fluvirin on 10/14/2003. On 10/14/2003 an unspecified number of vaccinees received double the recommended dose of Fluvirin.  The reporter did not have vaccinee demographics or specifics on any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 20 February 2004. A follow-up report was received from a healthcare professional indicating that 96 females, 29 males and 23 vaccinees of unspecified gender and all of unknown age received Fluvirin.  No adverse events were reported. No follow-up pending, all information received.
Injection site erythema, induration, tenderness, swelling, pain. Grade 3 w/ peak at about 24 hrs post-vaccination. Resolved 4 days post-vaccination.
3:20 Client stated she felt hot and her neck was red. We took her out observation area and took blood pressure. BP 130/88- P 75. The redness in her neck had spread to her face and ears.  At the time a whelp had started forming on her right cheek. We put an ice pack on her neck and started to fan her.  She stated that her face felt like it was swelling.  3:45 her redness had started to recede and she felt that her face was feeling better. We continued to monitor her symptoms and at 4:10 her spouse arrived to drive her home and the whelp was gone or right cheek, the redness had receded from her cheeks and ears. Her neck was not as red and she stated that she was not hot and she was able to return home.
patient has hx of Hodgkin's lymphoma . He presented with a 2 week hx of shortness of breath. He was diagnosed with COVID PNA on August 7 patient stated 02 sats would drop to 58%. He was placed on Hi flo oxygen and steroids. HE was diagnosed with worsening PNA . He continued to improve on his o2 level and was discharge with oxygen on 9/1/2021.
Patient describes soreness and redness in the arm, now it is still itching since January 1st
Recipient was 17yo when he received the first dose of COVID-19 Vaccine - Moderna.
I am a nurse practitioner employed by minute clinic. A colleague administered the vaccine (INFLUENZA 2008/2009) on 10/17/08. That evening I experienced true rigors lasting about 1 hr.
tongue is numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue is numb) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included no adverse drug effect.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (tongue is numb). At the time of the report, HYPOAESTHESIA ORAL (tongue is numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were provided No Treatment information provided
Patient stated her arm was very sore the next day. The pain continued and slowly moved down her arm to her elbow and forearm area. She stated that in late November/early December it moved in to her hand and continues to hurt. She is having a hard time gripping. She visited her family doctor on 2/12/19 and they are sending her for a test to see if she has nerve damage.
Patient c/o swelling and tenderness in her left clavicle area, enlarged lymph node under left clavicle, and body aches.
This spontaneous case reported by a pharmacist, describes the occurrence of COVID-19 (tested positive for COVID-19) and fatigue (feels tired) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 028A21A) for COVID-19 immunization. No medical history reported. On Mar 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 5, 2021, patient had COVID-19 (tested positive for COVID-19). On an unknown date, patient experienced fatigue (feels tired). At the time of the report, COVID-19 (tested positive for COVID-19) outcome: unknown; and fatigue (feels tired): not resolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment medication. This case linked to MOD-2021-089547 (E2B linked report). Sender's comments: MOD-2021-089547: wife's case.
swollen rt arm, itching, severe pain started 10/15/99 through 10/18/99; rx w/APAP PRN for pain;DPH, ice & heat alternate;DPH PRN for itching;pt states it was the pneumonia shot that caused the problem;
Received Flu vaccine on 9/27/2023 as an employee through Occupational Health.  Begin having pain that evening.  Was seen after approx 1 month for continued  left shoulder pain.  Reports diagnosed with subacromial bursitis.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 21-OCT-2012 20:52, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
The arm pit  got swollen up and the whole left side of the body started aching really badly. Could not move  around and  got headache and nausia too. That is still continuing  tiil date.
Pt received vaccine f/u with primary care provider for a rash that appeared after being vaccinated with the smallpox vaccine. Pt stated that he produced a rash that looked like pimples across his chest with no other concerns or symptoms.
approximately 7 hours post, fever (max 102, lasted 48 hours), severe body aches, headache, lethargic, lack of appetite, injection site swelling & soreness,high heart rate & blood sugars
Experienced fever of 104 Degrees of Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Experienced fever of 104 Degrees of Fahrenheit) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concomitant products included OXYCODONE HYDROCHLORIDE, PARACETAMOL (OXYCODONE AND ACETAMINOPHEN), METOPROLOL, WARFARIN, QUINAPRIL, LATANOPROST and PANTOPRAZOLE for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (Experienced fever of 104 Degrees of Fahrenheit). The patient was treated with IBUPROFEN on 17-Mar-2021 at an unspecified dose and frequency. At the time of the report, PYREXIA (Experienced fever of 104 Degrees of Fahrenheit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Body temperature: 104 (High) fever of 104 Degrees of Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Under my armpit was very painful. The next evening, I had an infection, and my arm was sore. I don't think it has anything to do with the vaccination, but it was also weird that I had big Lump on my left armpit.
Wheezing. --. Steroids inhaler 14 Day Severe Pain throughout every joint in my body and Throbbing head aches. ibuprofen 400mg  Forgetfulness and tightness around my chest.   Feeling sick for one week.
Itching and pain at injection site followed by pain for the next two days pain subsided, but itching persisted and worsened.  Injection site went from splotchy red day 1 to enlarged/red by 5 days post injection.  By 01/21/2021, the injection site was very red, raised, warm to touch and very itchy.  This continued through the weekend and by Sunday, the redness had spread .5-.75 inches, and fever (99.4-100.1) developed.  Fever subsided Monday morning but the injection spot redness continued to enlarge.  Primary Care physician was seen 1/25/2021 (today) and topical steroid and antibiotic was prescribed.
L upper outer arm w/ intense local rxn w/ warmth, redness and induration. Not very painful.
reports that noticed swelling around eyes approximately 4 hours after 1st dose of the Pfizer toddler dose vaccine. NO known allergies in the past. She had been well otherwise. No lip swelling, she denies any other discomfort. Parents gave 12.5mg of chewable Benadryl and swelling has gotten better over the last hour. Advise given to monitor for worsening swelling especially oral symptoms, cough. To ED if present. Benadryl 12.5mg ATC for the next 24 hours. Will f/u in the AM
alergic reaction (  swelling in the right face); pain in the left arm; This spontaneous case was reported by a patient and describes the occurrence of SWELLING FACE (alergic reaction (  swelling in the right face)) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced SWELLING FACE (alergic reaction (  swelling in the right face)) (seriousness criterion medically significant) and PAIN IN EXTREMITY (pain in the left arm). At the time of the report, SWELLING FACE (alergic reaction (  swelling in the right face)) and PAIN IN EXTREMITY (pain in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant history was not reported. The treatment history was not provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Caller's uncle tested positive 17 days after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller's uncle tested positive 17 days after receiving 1st dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced COVID-19 (Caller's uncle tested positive 17 days after receiving 1st dose). At the time of the report, COVID-19 (Caller's uncle tested positive 17 days after receiving 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, SARS-CoV-1 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Vaccine was administered on 8/24/22.  Patient developed symptoms 8/25/22. Patient experienced diffuse urticaria and itching. No swelling, shortness of breath, nausea, vomiting, diarrhea, or fever. They did not visit an urgent care clinic or emergency department. Patient visited internal medicine office on 8/26/22 as symptoms had not resolved. Patient was prescribed antihistamines and Medrol dose-pak.